The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer

Gynecologic Oncology

Volumn 132, Issue 3, 2014, Pages 739-744

  Chan, John K ^a   Blansit, Kevin ^a   Kiet, Tuyen ^a   Sherman, Alexander ^a   Wong, Gabriel ^a   Earle, Christine ^a   Bourguignon, Lilly Y W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chemoresistance; Chemosensitivity; MicroRNA; miR 21; Ovarian cancer

Indexed keywords

ANTIMICRORNA 21 MIRIDIAN HAIRPIN INHIBITOR; ANTINEOPLASTIC AGENT; CISPLATIN; LIPOCORTIN 5; MICRORNA 21; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CHEMOSENSITIVITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN FUNCTION; PROTEIN MICROARRAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

CHEMORESISTANCE; CHEMOSENSITIVITY; MICRORNA; MIR-21; OVARIAN CANCER;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; TRANSFECTION;

EID: 84896391054     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.01.034     Document Type: Article

References (40)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. W.M. Merritt, Y.G. Lin, L.Y. Han, A.A. Kamat, W.A. Spannuth, and R. Schmandt et al. Dicer, Drosha, and outcomes in patients with ovarian cancer N Engl J Med 359 2008 2641 2650
3. O. Kovalchuk, J. Filkowski, J. Meservy, Y. Ilnytskyy, V.P. Tryndyak, and V.F. Chekhun et al. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin Mol Cancer Ther 7 2008 2152 2159
4. T.E. Miller, K. Ghoshal, B. Ramaswamy, S. Roy, J. Datta, and C.L. Shapiro et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1 J Biol Chem 283 2008 29897 29903
5. A. Sorrentino, C.G. Liu, A. Addario, C. Peschle, G. Scambia, and C. Ferlini Role of microRNAs in drug-resistant ovarian cancer cells Gynecol Oncol 111 2008 478 486
6. D.R. Cochrane, N.S. Spoelstra, E.N. Howe, S.K. Nordeen, and J.K. Richer MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents Mol Cancer Ther 8 2009 1055 1066
7. R. Eitan, M. Kushnir, G. Lithwick-Yanai, M.B. David, M. Hoshen, and M. Glezerman et al. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients Gynecol Oncol 114 2009 253 259
8. L.Y. Bourguignon, C.C. Spevak, G. Wong, W. Xia, and E. Gilad Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells J Biol Chem 284 2009 26533 26546
9. J.H. Hwang, J. Voortman, E. Giovannetti, S.M. Steinberg, L.G. Leon, and Y.T. Kim et al. Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer PLoS One 5 2010 e10630
10. E. Giovannetti, N. Funel, G.J. Peters, M. Del Chiaro, L.A. Erozenci, and E. Vasile et al. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity Cancer Res 70 2010 4528 4538
11. H. Yang, W. Kong, L. He, J.J. Zhao, J.D. O'Donnell, and J. Wang et al. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN Cancer Res 68 2008 425 433
12. Z. Li, S. Hu, J. Wang, J. Cai, L. Xiao, and L. Yu et al. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells Gynecol Oncol 119 2010 125 130
13. M.V. Iorio, M. Ferracin, C.G. Liu, A. Veronese, R. Spizzo, and S. Sabbioni et al. MicroRNA gene expression deregulation in human breast cancer Cancer Res 65 2005 7065 7070
14. Y.H. Lou, X.S. Yang, F.L. Wang, J.H. Qian, and Y. Huang Expression of microRNA-21 in ovarian epithelial carcinoma and its clinical significance Nan Fang Yi Ke Da Xue Xue Bao 30 2010 608 610 [613]
15. L.Y. Bourguignon, C. Earle, G. Wong, C.C. Spevak, and K. Krueger Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells Oncogene 31 2012 149 160
16. M.L. Si, S. Zhu, H. Wu, Z. Lu, F. Wu, and Y.Y. Mo miR-21-mediated tumor growth Oncogene 26 2007 2799 2803
17. E.J. Nam, H. Yoon, S.W. Kim, H. Kim, Y.T. Kim, and J.H. Kim et al. MicroRNA expression profiles in serous ovarian carcinoma Clin Cancer Res 14 2008 2690 2695
18. Y. Lou, X. Yang, F. Wang, Z. Cui, and Y. Huang MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein Int J Mol Med 26 2010 819 827
19. I. Reichenstein, N. Aizenberg, M. Goshen, Z. Bentwich, and Y.S. Avni A novel qPCR assay for viral encoded microRNAs J Virol Methods 163 2010 323 328
20. Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
21. N.S. Wickramasinghe, T.T. Manavalan, S.M. Dougherty, K.A. Riggs, Y. Li, and C.M. Klinge Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells Nucleic Acids Res 37 2009 2584 2595
22. I.A. Asangani, S.A. Rasheed, D.A. Nikolova, J.H. Leupold, N.H. Colburn, and S. Post et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer Oncogene 27 2008 2128 2136
23. C. Gong, Y. Yao, Y. Wang, B. Liu, W. Wu, and J. Chen et al. Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer J Biol Chem 286 2011 19127 19137
24. D.D. Taylor, and C. Gercel-Taylor MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer Gynecol Oncol 110 2008 13 21
25. Y. Lou, Z. Cui, F. Wang, X. Yang, and J. Qian miR-21 down-regulation promotes apoptosis and inhibits invasion and migration abilities of OVCAR3 cells Clin Invest Med 34 2011 E281
26. N. Zaffaroni, and M.G. Daidone Survivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventions Drug Resist Updat 5 2002 65 72
27. L. Hu, C. McArthur, and R.B. Jaffe Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant Br J Cancer 102 2010 1276 1283
28. R. Harfouche, H.M. Hassessian, Y. Guo, V. Faivre, C.B. Srikant, and G.D. Yancopoulos et al. Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells Microvasc Res 64 2002 135 147
29. J. Tran, J. Rak, C. Sheehan, S.D. Saibil, E. LaCasse, and R.G. Korneluk et al. Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells Biochem Biophys Res Commun 264 1999 781 788
30. G. Marioni, A. Bertolin, L. Giacomelli, R. Marchese-Ragona, M. Savastano, and N. Calgaro et al. Expression of the apoptosis inhibitor protein Survivin in primary laryngeal carcinoma and cervical lymph node metastasis Anticancer Res 26 2006 3813 3817
31. E. Osaka, T. Suzuki, S. Osaka, Y. Yoshida, H. Sugita, and S. Asami et al. Survivin as a prognostic factor for osteosarcoma patients Acta Histochem Cytochem 39 2006 95 100
32. A.M. Hunter, E.C. LaCasse, and R.G. Korneluk The inhibitors of apoptosis (IAPs) as cancer targets Apoptosis 12 2007 1543 1568
33. E.C. LaCasse, S. Baird, R.G. Korneluk, and A.E. MacKenzie The inhibitors of apoptosis (IAPs) and their emerging role in cancer Oncogene 17 1998 3247 3259
34. A.B. Gaur, S.L. Holbeck, N.H. Colburn, and M.A. Israel Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo Neuro Oncol 13 2011 580 590
35. S.T. Beug, H.H. Cheung, E.C. LaCasse, and R.G. Korneluk Modulation of immune signalling by inhibitors of apoptosis Trends Immunol 33 2012 535 545
36. K. Miura, H. Karasawa, and I. Sasaki cIAP2 as a therapeutic target in colorectal cancer and other malignancies Expert Opin Ther Targets 13 2009 1333 1345
37. C.S. Mitsiades, N. Mitsiades, V. Poulaki, R. Schlossman, M. Akiyama, and D. Chauhan et al. Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications Oncogene 21 2002 5673 5683
38. S.K. Lee, S.B. Kim, J.S. Kim, C.H. Moon, M.S. Han, and B.J. Lee et al. Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines Int J Cancer 117 2005 32 40
39. A.K.T. Sultan, J. Chan, Y. Wang, and B. Francisco Significance of MicroRNAs in determining taxane resistance in ovarian cancer Gynecol Oncol 2012
40. A.F.K. Sherman, J. Korkola, D. Levine, A. Olshen, and J. Chan Differential microRNA expression may predict for cisplatinum resistance in advanced serous ovarian cancer 2010 Western associiation of gynecologic oncologists